文摘
The synthesis and examination of a novel class of reversed CPyI analogues of CC-1065 and theduocarmycins are described. Capable of a unique metal cation activation of DNA alkylation, these agentsallowed the effects of the DNA binding domain (104-fold increase in DNA alkylation rate and efficiency) tobe partitioned into two components: that derived from enhanced DNA binding affinity and selectivity (10-80-fold) and that derived from a contribution to catalysis (250-5000-fold). In addition, the reversed enantiomericselectivity of these sequence selective DNA alkylating agents provides further strong support for a previouslydisclosed model where it is the noncovalent binding selectivity of the compounds, and not the alkylationsubunit or the source of catalysis, that controls the DNA alkylation selectivity.